-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Castle Biosciences Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2025.
- Castle Biosciences Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$770K.
- Castle Biosciences Inc annual Deferred Income Tax Expense (Benefit) for 2024 was $1.4M.
- Castle Biosciences Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$223K, a 88.1% increase from 2022.
- Castle Biosciences Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.88M, a 78.5% increase from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)